Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review

The outcome of colorectal cancer (CRC) can be improved by the identification of prognostic biomarkers. This systematic review of observational cohort and case-control studies was conducted to investigate the role of Endoglin (CD105) in the prognosis of CRC. The databases PubMed, Web of Science, Scop...

Descripción completa

Detalles Bibliográficos
Autores principales: Sur, Daniel, Havasi, Andrei, Lungulescu, Cristian Virgil, Volovat, Simona Ruxandra, Burz, Claudia, Irimie, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387571/
https://www.ncbi.nlm.nih.gov/pubmed/36060514
http://dx.doi.org/10.15386/mpr-2120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387571/
https://www.ncbi.nlm.nih.gov/pubmed/36060514
http://dx.doi.org/10.15386/mpr-2120

Ejemplares similares